Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
Clinical trial NCT03897088 · COMPLETED
Trial details
- NCT number
- NCT03897088
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2022-02-17
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.